Signed in as:
filler@godaddy.com
Our Approach to Treat a Range of Aggressive Cancers
At iPSirius, we are developing active immunotherapies based on Induced Pluripotent Stem Cells (iPSC) that presents a new avenue for treating a variety of late stage cancers with a stemness signature including non-small cell lung cancer, glioblastoma, triple negative breast cancer and pancreatic cancer.
Our products can be administered as single agent or in combination with other therapies to enhance anti-tumor immunity improving prognoses and therapeutic options for patients.